Results 161 to 170 of about 30,982 (215)

Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans. [PDF]

Sci Rep
Heinrich F, Lücke J, Zhang S, Sabihi M, Bernreuther C, Giersch K, Allweiss L, Hartmann K, Thies E, Lange P, Matschke J, Kühl AA, Mothes R, Radbruch H, Schröder AS, Heinemann A, Dandri M, Aepfelbacher M, Huber S, Giannou A, Glatzel M, Ondruschka B, Lütgehetmann M, Krasemann S.   +23 more
europepmc   +1 more source

COVID-19 mRNA Vaccines as Antigen-Agnostic Immunomodulators: A Repurposing Perspective. [PDF]

Med Sci (Basel)
Minoretti P, Emanuele E.
europepmc   +1 more source

Correction: Rzymski, P. Potential Non-Specific Benefits of Seasonal Influenza Vaccination: Evidence, Knowledge Gaps, and Future Directions. <i>Vaccines</i> 2026, <i>14</i>, 207. [PDF]

Vaccines (Basel)
Rzymski P.
europepmc   +1 more source

Metabolic impairments in peripheral blood mononuclear cells after BNT162b2 vaccination in liver transplantation adolescents. [PDF]

Sci Rep
Buranapraditkun S, Kitkumthorn N, Chaiwongkot A, Thantiworasit P, Sintusek P.   +4 more
europepmc   +1 more source

Occurrence of Myocarditis in Patients Immunized with Different Types of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. [PDF]

Virus Res
Valenzuela-Fuenzalida JJ, Valarezo LM, Silva V, Delgado F, Nazar-Izquierdo D, Bruna-Mejias A, Nova-Baeza P, Donoso MO, Amaro GO, Cifuentes-Suazo G, Moya MP, Gimeno JS, Konschake M, Loaiza-Giraldo JP.   +13 more
europepmc   +1 more source

BNT162b2 vaccine for prevention of COVID-19

, 2021
openaire   +1 more source

Subacute-Onset Anemia Following COVID-19 Vaccine Combination with ChAdOx (AstraZeneca) and BNT162b2 (BioNTech, Pfizer)-A Case Report. [PDF]

Reports (MDPI)
Salveridou K, Tzamalis T, Haase S, Giagounidis A.   +3 more
europepmc   +1 more source

Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old. [PDF]

Clin Infect Dis
Winokur P, Diya O, Fitz-Patrick D, Dever M, Gayed J, Lockhart S, Xu X, Zhang Y, Bangad V, Wadsworth LT, Cannon K, Cardona JF, Usdan L, Ginis J, Mensa FJ, Zou J, Xie X, Lu C, Buitrago S, Scully IL, Cooper D, Koury K, Jansen KU, Türeci Ö, Şahin U, Swanson KA, Gruber WC, Kitchin N.   +27 more
europepmc   +1 more source

Distinct Innate Immune Responses Following Inoculation With a Replicon mRNA COVID-19 Vaccine. [PDF]

Microbiol Immunol
Nakayama T, Ito T, Katayama K.
europepmc   +1 more source

Optimizing mouse models for mRNA vaccines: addressing dose translation challenges. [PDF]

Sci Rep
Chang ZW, Tan YJ, Liao Y, Goh YS, Kabir SR, Wang Y, Hor PX, Loh CY, Huang Y, Wang B, Salleh SNM, Ngoh EZX, COVID-19 Cohort Study Group, NCID Study Group, COVID-19 Clinicians’ Group, Wang CI, Lye DC, Young BE, Tay MZ, Ng LFP, Ejima K, Renia L.   +21 more
europepmc   +1 more source